To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
33 Current newsrss
Total revenues increase 20% to record EUR 9.3 billion
The Merck Group’s total revenues for 2010 increased 20% to a record EUR 9,291 million from EUR 7,747 million in 2009, boosted by the EUR 5.1 billion acquisition of Millipore Corporation in July...
in 2009. Due to interest payments on the financing for Millipore, Merck’s financial result more than doubled to EUR –78 million in the second quarter. For the half year, the financial result was EUR –117...
Merck Chemicals now comprises two new divisions: Merck Millipore and Performance Materials
Merck KGaA announced the successful completion of its acquisition of Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price...
2010 Group guidance raised: operating result to improve by +30% to +40%
for the financing of the planned acquisition of Millipore Corporation in the United States, leading to a first-quarter decline of 11% in the financial results to EUR –39 million from EUR –35 million. In spite of that...
Combination will create a € 2.1 billion (US$ 2.9 billion) partner for the Life Science sector and transform Merck Chemicals
Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107...
John Sweeney to focus on technology development and partnerships
Millipore Corporation announced the appointment of John Sweeney as Vice President of Millipore’s Life Science SBU. Most recently, Sweeney served as Vice President of Strategy and Marketing services...
Acquisition extends Millipore’s biopharmaceutical services offering to European market
Millipore Corporation announced it has acquired BioAnaLab, a European-based services provider that specializes in the analysis of biologic drugs and vaccines. The transaction enables Millipore...
Board of Directors Chairman Mike Baronian will not stand for re-election at the ordinary Annual General Meeting 2009
in Strasbourg, France, in Pharmacy. He is a French and US citizen. From 1972 until 2008, Dominique F. Baly held various top management positions at Millipore Corporation in Europe and in the US, including...